---
schema_version: "secwatch.filing_event.v1"
accession: "0000926617-26-000047"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2026-06-22T13:13:14+00:00"
generated_at: "2026-06-22T13:14:09.722348+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health CEO Michael Buhle departs; Chairman John Fraser named interim CEO

## Summary
- Michael Buhle ceased as CEO effective June 17, 2026; no disagreement with company operations.
- Board appointed Chairman John Fraser as Interim CEO and Principal Executive Officer.
- Separation agreement with Buhle not yet finalized; Company will file amendment within 4 business days.
- John Fraser, age 66, is co-founder and co-portfolio manager of Seamark Capital.

## SEC filing metadata
- accession: 0000926617-26-000047
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2026-06-22T13:13:14+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000092661726000047/0000926617-26-000047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000092661726000047/awhl-20260617x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926617-26-000047
- JSON: https://secwatch.observer/filing/0000926617-26-000047.json
- Plain text: https://secwatch.observer/filing/0000926617-26-000047.txt

## Key facts
- Executive change
  John Fraser was appointed as Interim Chief Executive Officer at Aspira Women's Health Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: Effective June 17, 2026, the board of directors (the “Board”) of the Company appointed John Fraser, the Company’s current Chairman of the Board, to serve as its Interim Chief Executive Officer while a search of internal and external candidates is conducted.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661726000047/0000926617-26-000047-index.htm
- Executive change
  Michael Buhle departed as Chief Executive Officer at Aspira Women's Health Inc..
  - Action: ceased serving
  - Role: Chief Executive Officer
  source text: On June 17, 2026, Michael Buhle ceased serving as Chief Executive Officer of Aspira Women's Health Inc. (the "Company").
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661726000047/0000926617-26-000047-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.